The cambridge peanut allergy clinic: Real world safety and efficacy outcomes during oral immunotherapy with characterised peanut flour

被引：0
|
作者：
Clark, A. [1 ]
Zolkipli, Q. [1 ]
Ewan, P. [1 ]
机构：
[1] Cambridge Univ Hosp, Cambridge, England
来源：
ALLERGY | 2019年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
OA0022
引用
收藏
页码：15 / 16
页数：2
相关论文
共 50 条
  • [1] Real world safety and efficacy outcomes during oral immunotherapy with characterised peanut protein
    Clark, Andrew
    Zolkipli, Quiza
    Tibbott, Rebecca
    Ewan, Pamela
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB140 - AB140
  • [2] OUTCOMES OF PEANUT ORAL IMMUNOTHERAPY IN AN ALLERGY CLINIC
    Shroba, J.
    Bandelier, C.
    Pandya, A.
    Parashar, S.
    Portnoy, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S43 - S43
  • [3] Identifying Candidates for Real-World Peanut Oral Immunotherapy in the Allergy Clinic
    Blackman, Andrea
    Anagnostou, Aikaterini
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB107 - AB107
  • [4] Improvement in quality of life following peanut oral immunotherapy in a paediatric population at the Cambridge Peanut Allergy Clinic
    Powell, Elizabeth
    Zolkipli, Zaraquiza Q.
    Hadjiyiannis, Demetra
    Ewan, Pamela
    Clark, Andrew
    CLINICAL AND EXPERIMENTAL ALLERGY, 2019, 49 (12): : 1653 - 1653
  • [5] Improvement in quality of life following peanut oral immunotherapy in a paediatric population at the Cambridge Peanut Allergy Clinic
    Powell, Elizabeth
    Zolkipli, Quiza
    Ewan, Pamela
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB137 - AB137
  • [6] Good safety profile, efficacy and few withdrawals during oral immunotherapy with characterised GMP peanut protein in a real-world setting
    Clark, A.
    Zolkipli, Q.
    Powell, E.
    Ewan, P.
    ALLERGY, 2020, 75 : 117 - 118
  • [7] Safety of a peanut oral immunotherapy protocol in children with peanut allergy
    Hofmann, Alison M.
    Scurlock, Amy M.
    Jones, Stacie M.
    Palmer, Kricia P.
    Lokhnygina, Yuliya
    Steele, Pamela H.
    Kamilaris, Janet
    Burks, A. Wesley
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 124 (02) : 286 - 291
  • [8] Efficacy and safety of oral immunotherapy for peanut allergy in children aged 1 to
    Bluemchen, K.
    Tilles, S.
    Ortiz, A. Vereda
    Brown, K.
    du Toit, G.
    ALLERGY, 2023, 78 : 11 - 11
  • [9] Establishing Safety of Alternating Peanut Products during Real-World Peanut Oral Immunotherapy using Equivalency Challenges
    Magier, Adam
    Wilson, Bridget
    Devonshire, Ashley
    Andorf, Sandra
    Madis, Erick
    Rosenberg, Chen
    Assa'ad, Amal
    Durrani, Sandy
    Schwartz, Justin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB140 - AB140
  • [10] Efficacy and safety of oral immunotherapy for peanut allergy: a pilot study in Singaporean children
    Zhong, Youjia
    Chew, Jian-Ming Lamony
    Tan, Michelle Meiling
    Soh, Jian Yi
    ASIA PACIFIC ALLERGY, 2019, 9 (01)
12345